Recently published Agitation in Alzheimer's Disease Market Insights report includes a comprehensive understanding of current ...
Morning Overview on MSN
The ETH Zurich team behind the new Alzheimer’s compound is hunting a drugmaker to carry it forward
Researchers at ETH Zurich have identified a compound that targets a previously overlooked protein aggregation mechanism in ...
We are living in an exciting new era for Alzheimer’s treatment. For the first time, therapies can slow the disease for some ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer's disease, the road to a cure seems long and uncertain. But as the year comes to a close, experts are ...
"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results